QS Investors’s Accelerate Diagnostics AXDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-2
Closed -$1K 1899
2018
Q3
$1K Hold
2
﹤0.01% 1703
2018
Q2
$1K Hold
2
﹤0.01% 1722
2018
Q1
$1K Hold
2
﹤0.01% 1726
2017
Q4
$1K Hold
2
﹤0.01% 1735
2017
Q3
$1K Hold
2
﹤0.01% 1702
2017
Q2
$1K Hold
2
﹤0.01% 1710
2017
Q1
$1K Hold
2
﹤0.01% 1730
2016
Q4
$1K Hold
2
﹤0.01% 1537
2016
Q3
$1K Hold
2
﹤0.01% 1523
2016
Q2
$1K Buy
+2
New +$268 ﹤0.01% 1546
2016
Q1
Sell
-1
Closed -$1K 1985
2015
Q4
$1K Buy
+1
New +$183 ﹤0.01% 1556

Other funds holding AXDX

QS Investors's AXDX Position: Q4 2018 in Review

QS Investors sold out of Accelerate Diagnostics (AXDX) in Q4 2018, closing a stake of 2 shares — an estimated $1K sold.

QS Investors first reported a position in AXDX in Q4 2015 and held it in 11 quarters. The position peaked at $1K in Q3 2018. 107 funds tracked by Wall St. Rank hold AXDX as of Q4 2018.

  • QS Investors reported no remaining Accelerate Diagnostics position as of Q4 2018 after selling out during the quarter.
  • QS Investors sold 2 Accelerate Diagnostics shares in Q4 2018, an estimated $1K.
  • QS Investors first reported a position in Accelerate Diagnostics in Q4 2015 and held it in 11 quarters.
  • QS Investors's Accelerate Diagnostics position peaked at $1K in Q3 2018.
  • 107 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q4 2018.

Based on QS Investors's 13F filing for Q4 2018, filed 14 Feb 2019.